25312, a novel human agmatinase-like homolog
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 2, 2006
Grant Date -
Nov 6, 2003
app pub date -
Jun 12, 2003
filing date -
Feb 28, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to a newly identified human agmatinase-like arginase, designated '25312'. The invention also relates to polynucleotides encoding the agmatinase-like arginase. The invention further relates to methods using the agmatinase-like polypeptides and polynucleotides as a target for diagnosis and treatment in disorders mediated by or related to the agmatinase-like arginase. The invention further relates to drug-screening methods using the polypeptides and polynucleotides to identify agonists and antagonists for diagnosis and treatment. The invention further encompasses agonists and antagonists based on the polypeptides and polynucleotides. The invention further relates to agonists and antagonists identified by drug screening methods with the polypeptides and polynucleotides as a target.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully